Clopidogrel discontinuation after myocardial infarction and risk of thrombosis - Alle medarbejdere på Institut for Folkesundhedsvidenskab

Clopidogrel discontinuation after myocardial infarction and risk of thrombosis: a nationwide cohort study

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

Præsentation
Citationsformater

Mette Charlot
Lars Hougaard Nielsen
Jesper Lindhardsen
Ole Ahlehoff
Anne-Marie S Olsen
Morten Lock Hansen
Hansen, Peter Riis
Jan Kyst Madsen
Køber, Lars Valeur
Gislason, Gunnar Hilmar
Torp-Pedersen, Christian Tobias

The benefit of extending clopidogrel treatment beyond the 12-month period recommended in current guidelines after myocardial infarction (MI) is debated. We analysed the risk of adverse cardiovascular outcomes after discontinuation of 12 months of clopidogrel treatment.

Originalsprog	Engelsk
Tidsskrift	European Heart Journal
Vol/bind	33
Udgave nummer	20
Sider (fra-til)	2527-34
Antal sider	8
ISSN	0195-668X
DOI	https://doi.org/10.1093/eurheartj/ehs202
Status	Udgivet - 2012

ID: 48453033